Our results suggest strengthening the monitoring of young patients with primary tumors in the small intestine and those with high-risk tumors or KIT exon 9 insertion or KIT exon 11 deletions at time of diagnosis to ensure early detection of potential tumor progression and timely treatment. The gene discussed is KIT; the disease is neoplasm.